Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks.

Saadah NH, Schipperus MR, Wiersum-Osselton JC, van Kraaij MG, Caram-Deelder C, Beckers EAM, Leyte A, Rondeel JMM, de Vooght KMK, Weerkamp F, Zwaginga JJ, van der Bom JG.

Haematologica. 2019 Jul 4. pii: haematol.2019.222083. doi: 10.3324/haematol.2019.222083. [Epub ahead of print]

2.

Long-term evaluation of allogeneic bone marrow-derived mesenchymal stromal cell therapy for Crohn's disease perianal fistulas.

Barnhoorn MC, Wasser MNJM, Roelofs H, Maljaars PWJ, Molendijk I, Bonsing BA, Oosten LEM, Dijkstra G, van der Woude CJ, Roelen DL, Zwaginga JJ, Verspaget HW, Fibbe WE, Hommes DW, Peeters KCMJ, van der Meulen-de Jong AE.

J Crohns Colitis. 2019 Jun 14. pii: jjz116. doi: 10.1093/ecco-jcc/jjz116. [Epub ahead of print]

PMID:
31197361
3.

Fluid resuscitation during persistent postpartum haemorrhage and maternal outcome: A nationwide cohort study.

Henriquez DDCA, Bloemenkamp KWM, Loeff RM, Zwart JJ, van Roosmalen JJM, Zwaginga JJ, van der Bom JG; TeMpOH-1 study group.

Eur J Obstet Gynecol Reprod Biol. 2019 Apr;235:49-56. doi: 10.1016/j.ejogrb.2019.01.027. Epub 2019 Feb 4.

PMID:
30784827
4.

Plasma thrombopoietin levels as additional tool in clinical management of thrombocytopenic neonates.

Porcelijn L, Huiskes E, Onderwater-Van Den Hoogen L, Folman CC, Zwaginga JJ, De Haas M.

Platelets. 2019 Feb 13:1-6. doi: 10.1080/09537104.2019.1572877. [Epub ahead of print]

PMID:
30759044
5.

CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II.

van Balen P, van Bergen CAM, van Luxemburg-Heijs SAP, de Klerk W, van Egmond EHM, Veld SAJ, Halkes CJM, Zwaginga JJ, Griffioen M, Jedema I, Falkenburg JHF.

Front Immunol. 2018 Dec 18;9:3016. doi: 10.3389/fimmu.2018.03016. eCollection 2018.

6.

Intramyocardial bone marrow cell injection does not lead to functional improvement in patients with chronic ischaemic heart failure without considerable ischaemia.

Mann I, Tseng CCS, Rodrigo SF, Koudstaal S, van Ramshorst J, Beeres SL, Dibbets-Schneider P, de Geus-Oei LF, Lamb HJ, Wolterbeek R, Zwaginga JJ, Fibbe WE, Westinga K, Bax JJ, Doevendans PA, Schalij MJ, Chamuleau SAJ, Atsma DE.

Neth Heart J. 2019 Feb;27(2):81-92. doi: 10.1007/s12471-018-1213-2.

7.

The role of pathogen-reduced platelet transfusions on HLA alloimmunization in hemato-oncological patients.

Saris A, Kerkhoffs JL, Norris PJ, van Ham SM, Ten Brinke A, Brand A, van der Meer PF, Zwaginga JJ.

Transfusion. 2019 Feb;59(2):470-481. doi: 10.1111/trf.15056. Epub 2018 Nov 30.

PMID:
30499599
8.

Restrictive guideline for red blood cell transfusions in preterm neonates: effect of a protocol change.

Heeger LE, Counsilman CE, Bekker V, Bergman KA, Zwaginga JJ, Te Pas AB, Lopriore E.

Vox Sang. 2019 Jan;114(1):57-62. doi: 10.1111/vox.12724. Epub 2018 Nov 8.

PMID:
30407636
9.

The burden of invasive infections in neutropenic patients: incidence, outcomes, and use of granulocyte transfusions.

Netelenbos T, Massey E, de Wreede LC, Harding K, Hamblin A, Sekhar M, Li A, Ypma PF, Ball L, Zwaginga JJ, Stanworth SJ.

Transfusion. 2019 Jan;59(1):160-168. doi: 10.1111/trf.14994. Epub 2018 Nov 1.

PMID:
30383912
10.

The quality of platelet concentrates related to corrected count increment: linking in vitro to in vivo.

Saris A, Kreuger AL, Ten Brinke A, Kerkhoffs JLH, Middelburg RA, Zwaginga JJ, van der Meer PF.

Transfusion. 2019 Feb;59(2):697-706. doi: 10.1111/trf.14868. Epub 2018 Sep 18.

PMID:
30226275
11.

Patient blood management in colorectal cancer patients: a survey among Dutch gastroenterologists, surgeons, and anesthesiologists.

Wilson MJ, Koopman-van Gemert AWMM, Harlaar JJ, Jeekel J, Zwaginga JJ, Schipperus M.

Transfusion. 2018 Oct;58(10):2345-2351. doi: 10.1111/trf.14807. Epub 2018 Sep 10.

PMID:
30203500
12.

The identification of cases of major hemorrhage during hospitalization in patients with acute leukemia using routinely recorded healthcare data.

Kreuger AL, Middelburg RA, Beckers EAM, de Vooght KMK, Zwaginga JJ, Kerkhoffs JH, van der Bom JG.

PLoS One. 2018 Aug 15;13(8):e0200655. doi: 10.1371/journal.pone.0200655. eCollection 2018.

13.

Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision model.

Thielen FW, Blommestein HM, Oosten LEM, Calkoen FG, Lankester AC, Zwaginga JJ, Le Blanc K, Redondo A, Sánchez-Guijo F, Algeri M, Locatelli F, Fibbe WE, Uyl-de Groot CA.

Eur J Haematol. 2018 Aug 6. doi: 10.1111/ejh.13158. [Epub ahead of print]

PMID:
30084111
14.

Bone marrow iron score as an indicator for secondary iron overload in acute myeloid leukemia patients.

Hoeks M, van der Pol M, Middelburg R, Evers D, van Kraaij M, Zwaginga JJ.

Eur J Haematol. 2018 Jul 17. doi: 10.1111/ejh.13145. [Epub ahead of print]

PMID:
30014522
15.

No Clinical Benefit of Intramuscular Delivery of Bone Marrow-derived Mononuclear Cells in Nonreconstructable Peripheral Arterial Disease: Results of a Phase-III Randomized-controlled Trial.

Lindeman JHN, Zwaginga JJ, Kallenberg-Lantrua G, van Wissen RC, Schepers A, van Bockel HJ, Fibbe WE, Hamming JF.

Ann Surg. 2018 Nov;268(5):756-761. doi: 10.1097/SLA.0000000000002896.

PMID:
30004916
16.

Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion.

Saris A, Peyron I, van der Meer PF, Stuge TB, Zwaginga JJ, van Ham SM, Ten Brinke A.

Front Immunol. 2018 Jun 5;9:1251. doi: 10.3389/fimmu.2018.01251. eCollection 2018.

17.

The effect of intravenous iron therapy on long-term survival in anaemic colorectal cancer patients: Results from a matched cohort study.

Wilson MJ, Dekker JWT, Buettner S, Harlaar JJ, Jeekel J, Schipperus M, Zwaginga JJ.

Surg Oncol. 2018 Jun;27(2):192-199. doi: 10.1016/j.suronc.2018.03.005. Epub 2018 Mar 28.

PMID:
29937171
18.

Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art.

Porcelijn L, Huiskes E, Oldert G, Schipperus M, Zwaginga JJ, de Haas M.

Br J Haematol. 2018 Aug;182(3):423-426. doi: 10.1111/bjh.15404. Epub 2018 May 29.

PMID:
29808904
19.

Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial.

van der Meer PF, Ypma PF, van Geloven N, van Hilten JA, van Wordragen-Vlaswinkel RJ, Eissen O, Zwaginga JJ, Trus M, Beckers EAM, Te Boekhorst P, Tinmouth A, Lin Y, Hsia C, Lee D, Norris PJ, Goodrich RP, Brand A, Hervig T, Heddle NM, van der Bom JG, Kerkhoffs JH.

Blood. 2018 Jul 12;132(2):223-231. doi: 10.1182/blood-2018-02-831289. Epub 2018 May 17.

20.

Treatment and outcomes of fetal/neonatal alloimmune thrombocytopenia: a nationwide cohort study in newly detected cases.

Winkelhorst D, Oostweegel M, Porcelijn L, Middelburg RA, Zwaginga JJ, Oepkes D, van der Bom JG, de Haas M, Lopriore E.

Br J Haematol. 2019 Mar;184(6):1026-1029. doi: 10.1111/bjh.15216. Epub 2018 Apr 16. No abstract available.

PMID:
29682737
21.

Iron therapy as treatment of anemia: A potentially detrimental and hazardous strategy in colorectal cancer patients.

Wilson MJ, Harlaar JJ, Jeekel J, Schipperus M, Zwaginga JJ.

Med Hypotheses. 2018 Jan;110:110-113. doi: 10.1016/j.mehy.2017.12.011. Epub 2017 Dec 5.

22.

Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients.

Kruizinga MD, van Tol MJD, Bekker V, Netelenbos T, Smiers FJ, Bresters D, Jansen-Hoogendijk AM, van Ostaijen-Ten Dam MM, Kollen WJW, Zwaginga JJ, Lankester AC, Bredius RGM.

Biol Blood Marrow Transplant. 2018 Apr;24(4):772-778. doi: 10.1016/j.bbmt.2017.12.782. Epub 2017 Dec 19.

23.

Red blood cell transfusion support and management of secondary iron overload in patients with haematological malignancies in the Netherlands: a survey.

Hoeks MPA, Middelburg RA, Romeijn B, Blijlevens NMA, van Kraaij MGJ, Zwaginga JJ.

Vox Sang. 2018 Feb;113(2):152-159. doi: 10.1111/vox.12617. Epub 2017 Dec 19.

PMID:
29266372
24.

Short-term effect of preoperative intravenous iron therapy in colorectal cancer patients with anemia: results of a cohort study.

Wilson MJ, Dekker JW, Bruns E, Borstlap W, Jeekel J, Zwaginga JJ, Schipperus M.

Transfusion. 2018 Mar;58(3):795-803. doi: 10.1111/trf.14456. Epub 2017 Dec 17.

PMID:
29250797
25.

Platelets from donors with consistently low HLA-B8, -B12, or -B35 expression do not undergo antibody-mediated internalization.

Saris A, Tomson B, Brand A, Mulder A, Claas FH, Lorinser J, Scharenberg J, van Ham SM, Ten Brinke A, Zwaginga JJ, van der Meer PF.

Blood. 2018 Jan 4;131(1):144-152. doi: 10.1182/blood-2017-07-799270. Epub 2017 Nov 1.

26.

Age of platelet concentrates and time to the next transfusion.

Caram-Deelder C, van der Bom JG, Putter H, Leyte A, Kerkhof DV, Evers D, Beckers EA, Weerkamp F, Hudig F, Zwaginga JJ, Rondeel JMM, de Vooght KMK, Péquériaux NCV, Visser O, Wallis JP, Middelburg RA.

Transfusion. 2018 Jan;58(1):121-131. doi: 10.1111/trf.14388. Epub 2017 Oct 31.

PMID:
29090466
27.

The practice of diagnosing and reporting transfusion-associated circulatory overload: a national survey among physicians and haemovigilance officers.

Bosboom JJ, Klanderman RB, Peters AL, van de Weerdt EK, Goudswaard EJ, Binnekade JM, Zwaginga JJ, Beckers EAM, Geerts BF, Hollmann MW, Zeerleder SS, van Kraaij M, Vlaar AP.

Transfus Med. 2018 Oct;28(5):363-370. doi: 10.1111/tme.12480. Epub 2017 Oct 23.

PMID:
29058354
28.

Association of Blood Transfusion From Female Donors With and Without a History of Pregnancy With Mortality Among Male and Female Transfusion Recipients.

Caram-Deelder C, Kreuger AL, Evers D, de Vooght KMK, van de Kerkhof D, Visser O, Péquériaux NCV, Hudig F, Zwaginga JJ, van der Bom JG, Middelburg RA.

JAMA. 2017 Oct 17;318(15):1471-1478. doi: 10.1001/jama.2017.14825. Erratum in: JAMA. 2018 Feb 20;319(7):724.

29.

An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN study.

Zeller MP, Barty R, Dunbar NM, Elahie A, Flanagan P, Garritsen H, Kutner JM, Pagano MB, Pogłód R, Rogers TS, Staves J, van Wordragen-Vlaswinkel M, Zwaginga JJ, Murphy MF, Heddle NM, Yazer MH; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

Transfusion. 2018 Jan;58(1):151-157. doi: 10.1111/trf.14368. Epub 2017 Oct 14.

PMID:
29030954
30.

Identification of underlying and transfusion-related platelet qualitative alterations in the hemato-oncologic patient.

Vicente-Ayuso C, Papadopoulos P, Villa-Fajardo M, Prieto B, Álvarez-Carmona AM, Mateo-Morales M, Pérez-López C, Peña-Cortijo A, Polo-Zarzuela M, Sáez I, Martín MP, Benavente-Cuesta C, González-Fernández A, Martínez-Martínez R, Zwaginga JJ, Seghatchian J, Gutiérrez L.

Transfus Apher Sci. 2017 Oct;56(5):756-768. doi: 10.1016/j.transci.2017.08.020. Epub 2017 Aug 31. Review.

PMID:
28970003
31.

The role of preoperative iron deficiency in colorectal cancer patients: prevalence and treatment.

Wilson MJ, Dekker JWT, Harlaar JJ, Jeekel J, Schipperus M, Zwaginga JJ.

Int J Colorectal Dis. 2017 Nov;32(11):1617-1624. doi: 10.1007/s00384-017-2898-1. Epub 2017 Sep 9.

32.

Differential transcriptome of tolerogenic versus inflammatory dendritic cells points to modulated T1D genetic risk and enriched immune regulation.

Nikolic T, Woittiez NJC, van der Slik A, Laban S, Joosten A, Gysemans C, Mathieu C, Zwaginga JJ, Koeleman B, Roep BO.

Genes Immun. 2017 Sep;18(3):176-183. doi: 10.1038/gene.2017.18. Epub 2017 Aug 10.

PMID:
28794505
33.

Safety and efficacy of percutaneous intramyocardial bone marrow cell injection for chronic myocardial ischemia: Long-term results.

Rodrigo SF, Mann I, van Ramshorst J, Beeres SL, Zwaginga JJ, Fibbe WE, Bax JJ, Schalij MJ, Atsma DE.

J Interv Cardiol. 2017 Oct;30(5):440-447. doi: 10.1111/joic.12408. Epub 2017 Jul 28.

PMID:
28752630
34.

Storage time of platelet concentrates and all-cause bacteremia in hematologic patients.

Kreuger AL, Middelburg RA, Bank CMC, Beckers EAM, van Gammeren AJ, Leyte A, Rondeel JMM, de Vooght KMK, Weerkamp F, Zwaginga JJ, Kerkhoffs JLH, van der Bom JG.

Transfusion. 2017 Sep;57(9):2096-2103. doi: 10.1111/trf.14194. Epub 2017 Jun 26.

PMID:
28653425
35.

Impact of red blood cell transfusion strategies in haemato-oncological patients: a systematic review and meta-analysis.

Hoeks MPA, Kranenburg FJ, Middelburg RA, van Kraaij MGJ, Zwaginga JJ.

Br J Haematol. 2017 Jul;178(1):137-151. doi: 10.1111/bjh.14641. Epub 2017 Jun 7. Review.

PMID:
28589623
36.

Development of RBC transfusion indications and the collection of patient-specific pre-transfusion information.

Yazer MH, van de Watering L, Lozano M, Sirdesai S, Rushford K, Wood EM, Yokoyama AP, Kutner JM, Lin Y, Callum J, Cserti-Gazdewich C, Lieberman L, Pendergrast J, Pendry K, Murphy MF, Selleng K, Greinacher A, Marwaha N, Sharma R, Jain A, Orlin Y, Yahalom V, Perseghin P, Incontri A, Masera N, Okazaki H, Ikeda T, Nagura Y, Zwaginga JJ, Pogłod R, Rosiek A, Letowska M, Yuen J, Cid J, Harm SK, Adhikari P.

Vox Sang. 2017 Jul;112(5):e22-e47. doi: 10.1111/vox.12509. Epub 2017 May 19. No abstract available.

PMID:
28524359
37.

Development of RBC transfusion indications and the collection of patient-specific pre-transfusion information: summary.

Yazer MH, van de Watering L, Lozano M, Sirdesai S, Rushford K, Wood EM, Yokoyama AP, Kutner JM, Lin Y, Callum J, Cserti-Gazdewich C, Lieberman L, Pendergrast J, Pendry K, Murphy MF, Selleng K, Greinacher A, Marwaha N, Sharma R, Jain A, Orlin Y, Yahalom V, Perseghin P, Incontri A, Masera N, Okazaki H, Ikeda T, Nagura Y, Zwaginga JJ, Pogłod R, Rosiek A, Letowska M, Yuen J, Cid J, Harm SK, Adhikari P.

Vox Sang. 2017 Jul;112(5):487-494. doi: 10.1111/vox.12496. Epub 2017 May 19. No abstract available.

PMID:
28524235
38.

Reporting transfusion-related acute lung injury by clinical and preclinical disciplines.

Peters AL, Van De Weerdt EK, Goudswaard EJ, Binnekade JM, Zwaginga JJ, Beckers EAM, Zeerleder SS, Van Kraaij MGJ, Juffermans NP, Vlaar APJ.

Blood Transfus. 2018 May;16(3):227-234. doi: 10.2450/2017.0266-16. Epub 2017 Apr 5.

39.

Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients.

Porcelijn L, Huiskes E, Schipperus M, van der Holt B, de Haas M, Zwaginga JJ; Dutch HOVON 64 Study Group.

Blood. 2017 Jun 22;129(25):3389-3391. doi: 10.1182/blood-2016-11-751719. Epub 2017 May 3. No abstract available.

40.

Absence of the spleen and the occurrence of primary red cell alloimmunization in humans.

Evers D, van der Bom JG, Tijmensen J, de Haas M, Middelburg RA, de Vooght KMK, van de Kerkhof D, Visser O, Péquériaux NCV, Hudig F, Zwaginga JJ.

Haematologica. 2017 Aug;102(8):e289-e292. doi: 10.3324/haematol.2016.162685. Epub 2017 Apr 14. No abstract available.

41.

Long-term prognostic value of preoperative anemia in patients with colorectal cancer: A systematic review and meta-analysis.

Wilson MJ, van Haaren M, Harlaar JJ, Park HC, Bonjer HJ, Jeekel J, Zwaginga JJ, Schipperus M.

Surg Oncol. 2017 Mar;26(1):96-104. doi: 10.1016/j.suronc.2017.01.005. Epub 2017 Feb 2. Review.

PMID:
28317592
42.

Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.

van Oostrum A, Zwaginga JJ, Croockewit S, Overdevest J, Fechter M, Ruiterkamp B, Brand A, Netelenbos T.

J Clin Apher. 2017 Dec;32(6):397-404. doi: 10.1002/jca.21528. Epub 2017 Jan 31.

PMID:
28139098
43.

Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization.

Evers D, Zwaginga JJ, Tijmensen J, Middelburg RA, de Haas M, de Vooght KM, van de Kerkhof D, Visser O, Péquériaux NC, Hudig F, van der Bom JG.

Haematologica. 2017 Jan;102(1):52-59. doi: 10.3324/haematol.2016.152074. Epub 2016 Sep 15.

44.

Red cell alloimmunisation in patients with different types of infections.

Evers D, van der Bom JG, Tijmensen J, Middelburg RA, de Haas M, Zalpuri S, de Vooght KM, van de Kerkhof D, Visser O, Péquériaux NC, Hudig F, Zwaginga JJ.

Br J Haematol. 2016 Dec;175(5):956-966. doi: 10.1111/bjh.14307. Epub 2016 Aug 18.

PMID:
27539877
45.

Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study.

Evers D, Middelburg RA, de Haas M, Zalpuri S, de Vooght KM, van de Kerkhof D, Visser O, Péquériaux NC, Hudig F, Schonewille H, Zwaginga JJ, van der Bom JG.

Lancet Haematol. 2016 Jun;3(6):e284-92. doi: 10.1016/S2352-3026(16)30019-9. Epub 2016 May 9.

PMID:
27264038
46.

Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk.

Middelburg RA, Carbaat-Ham JC, Hesam H, Ragusi MA, Zwaginga JJ.

Hematology. 2016 Oct;21(9):549-51. doi: 10.1080/10245332.2016.1180097. Epub 2016 May 9.

PMID:
27159138
47.

Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia: a case series and review of the literature.

Winkelhorst D, Kamphuis MM, de Kloet LC, Zwaginga JJ, Oepkes D, Lopriore E.

Transfusion. 2016 May;56(5):1230-5. doi: 10.1111/trf.13550. Epub 2016 Mar 20.

PMID:
26996515
48.

Preparation of Cytokine-activated NK Cells for Use in Adoptive Cell Therapy in Cancer Patients: Protocol Optimization and Therapeutic Potential.

van Ostaijen-ten Dam MM, Prins HJ, Boerman GH, Vervat C, Pende D, Putter H, Lankester A, van Tol MJ, Zwaginga JJ, Schilham MW.

J Immunother. 2016 Feb-Mar;39(2):90-100. doi: 10.1097/CJI.0000000000000110.

PMID:
26849078
49.

A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema.

Stolk J, Broekman W, Mauad T, Zwaginga JJ, Roelofs H, Fibbe WE, Oostendorp J, Bajema I, Versteegh MI, Taube C, Hiemstra PS.

QJM. 2016 May;109(5):331-6. doi: 10.1093/qjmed/hcw001. Epub 2016 Jan 27.

50.

Reduction of healthcare utilization after bone marrow cell therapy for refractory angina pectoris.

Rodrigo SF, Mann I, van Ramshorst J, Beeres SL, Zwaginga JJ, Fibbe WE, Bax JJ, Schalij MJ, Atsma DE.

Int J Cardiol. 2016 Jan 1;202:571-2. doi: 10.1016/j.ijcard.2015.09.103. Epub 2015 Sep 28. No abstract available.

PMID:
26447664

Supplemental Content

Loading ...
Support Center